E-cadherin and B-catenin levels were also decreased though upon anti-Gas6 treatment, suggesting that Gas6 signaling partially regulates cancer cell plasticity, a phenomenon previously described in cancer (37, 38). The gene discussed is GAS6; the disease is cancer.